Bronx, N.Y. – – November 03, 2026 -- The National Cancer Institute (NCI) has awarded a five-year, $10 million grant to a multi-institutional team led by Julio A. Aguirre-Ghiso, Ph.D., of Montefiore Einstein Comprehensive Cancer Center (MECCC). The money will fund research into the biological processes behind breast cancer relapse and into ways to predict and prevent recurrence.

Jupiter, Florida – September 19, 2026 -- Myosin Therapeutics, Inc. has been selected as one of just 30 companies for the National Cancer Institute's 2026–2027 Investor Initiatives Showcase, a distinction drawn from NCI's full portfolio of funded companies following a competitive review by more than 70 third-party investors and strategic partners.